# Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension

> **NCT00523744** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 257 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Amlodipine
- **DRUG:** Olmesartan medoxomil
- **DRUG:** Amlodipine+valsartan
- **DRUG:** Hydrochlorothiazide

## Key facts

- **NCT ID:** NCT00523744
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 257 (ACTUAL)
- **Last updated:** 2020-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00523744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00523744, "Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00523744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*